EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients.
Kidney Int
; 99(5): 1225-1233, 2021 05.
Article
in En
| MEDLINE
| ID: mdl-33137340
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Polyamines
/
Hyperphosphatemia
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
Limits:
Humans
Language:
En
Journal:
Kidney Int
Year:
2021
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos